Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Proxy Statement filed

CJ, Cliff & Gloria

The first proposal on the agenda for the annual meeting will be electing three directors to serve until the next annual meeting or until their successors are elected. Our bylaws provide that the number of our directors may be no less than three and no more than seven, with the exact number to be fixed as the board determines. The Board has currently fixed the number of directors at five; effective upon the election of directors at the annual meeting, the Board has fixed the number of directors at three. There are three nominees for the three currently authorized seats on our board of directors. Unless authority to vote for directors has been withheld in the proxy, the persons named in the enclosed proxy intend to vote at the annual meeting FOR the election of the nominees presented below.

Share
New Message
Please login to post a reply